{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:22:00Z","timestamp":1788474120465,"version":"build-2803163510"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"DOI":"10.1007\/s00383-025-06116-5","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T10:39:46Z","timestamp":1753526386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Novel CTNNB1 gene mutations reveal critical pathogenic mechanisms in pediatric hepatoblastoma"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5840-9830","authenticated-orcid":false,"given":"Sourabh","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5579-3012","authenticated-orcid":false,"given":"Jyoti","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1243-4370","authenticated-orcid":false,"given":"Himani","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9273-097X","authenticated-orcid":false,"given":"Vishesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2050-7872","authenticated-orcid":false,"given":"Anjan Kumar","family":"Dhua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3158-1322","authenticated-orcid":false,"given":"Devendra Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6480-4249","authenticated-orcid":false,"given":"Devi","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6179-1625","authenticated-orcid":false,"given":"Prabudh","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"6116_CR1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.5582\/bst.2023.01311","volume":"17","author":"Y Cao","year":"2024","unstructured":"Cao Y, Wu S, Tang H (2024) An update on diagnosis and treatment of hepatoblastoma. Biosci Trends 17:445\u2013457","journal-title":"Biosci Trends"},{"key":"6116_CR2","doi-asserted-by":"crossref","first-page":"1309693","DOI":"10.3389\/fped.2024.1309693","volume":"12","author":"HS Wang","year":"2024","unstructured":"Wang HS, Lao J, Jiang RS, Wang B, Ma XP, Wang JY (2024) Summary of biological research on hepatoblastoma: a scoping review. Front Pediatr 12:1309693","journal-title":"Front Pediatr"},{"key":"6116_CR3","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1038\/s41467-021-25430-9","volume":"12","author":"G Nagae","year":"2021","unstructured":"Nagae G, Yamamoto S, Fujita M et al (2021) Genetic and epigenetic basis of hepatoblastoma diversity. Nat Commun 12:5423","journal-title":"Nat Commun"},{"key":"6116_CR4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jhep.2014.09.016","volume":"61","author":"MA Buendia","year":"2014","unstructured":"Buendia MA (2014) Unravelling the genetics of hepatoblastoma: few mutations, what else? J Hepatol 61:1202\u20131204","journal-title":"J Hepatol"},{"key":"6116_CR5","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1038\/s41586-018-0167-2","volume":"559","author":"SN Gr\u00f6bner","year":"2018","unstructured":"Gr\u00f6bner SN, Worst BC, Weischenfeldt J et al (2018) The landscape of genomic alterations across childhood cancers. Nature 559:E10","journal-title":"Nature"},{"key":"6116_CR6","first-page":"1","volume":"6","author":"IIP Lim","year":"2018","unstructured":"Lim IIP, Bondoc AJ, Geller JI, Tiao GM (2018) Hepatoblastoma-the evolution of biology, surgery, and transplantation. Children (Basel) 6:1","journal-title":"Children (Basel)"},{"key":"6116_CR7","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/hep.27243","volume":"60","author":"D Jia","year":"2014","unstructured":"Jia D, Dong R, Jing Y, Xu D, Wang Q, Chen L, Li Q, Huang Y, Zhang Y, Zhang Z, Liu L, Zheng S, Xia Q, Wang H, Dong K, He X (2014) Exome sequencing of hepatoblastoma reveals novel mutations and cancer genes in the Wnt pathway and ubiquitin ligase complex. Hepatology 60:1686\u20131696","journal-title":"Hepatology"},{"key":"6116_CR8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jhep.2020.03.025","volume":"73","author":"J Carrillo-Reixach","year":"2020","unstructured":"Carrillo-Reixach J, Torrens L, Simon-Coma M et al (2020) Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. J Hepatol 73:328\u2013341","journal-title":"J Hepatol"},{"key":"6116_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3727\/105221616X693639","volume":"17","author":"D Bell","year":"2017","unstructured":"Bell D, Ranganathan S, Tao J, Monga SP (2017) Novel advances in understanding of molecular pathogenesis of hepatoblastoma: a Wnt\/beta-catenin perspective. Gene Expr 17:141\u2013154","journal-title":"Gene Expr"},{"key":"6116_CR10","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1242\/dev.033910","volume":"136","author":"R van Amerongen","year":"2009","unstructured":"van Amerongen R, Nusse R (2009) Towards an integrated view of Wnt signaling in development. Development 136:3205\u20133214","journal-title":"Development"},{"key":"6116_CR11","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1186624","volume":"327","author":"Y Wang","year":"2010","unstructured":"Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z, Zon LI, Armstrong SA (2010) The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 327:1650\u20131653","journal-title":"Science"},{"key":"6116_CR12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13045-018-0656-7","volume":"11","author":"M Zhang","year":"2018","unstructured":"Zhang M, Weng W, Zhang Q, Wu Y, Ni S, Tan C, Xu M, Sun H, Liu C, Wei P, Du X (2018) The lncRNA NEAT1 activates Wnt\/\u03b2-catenin signaling and promotes colorectal cancer progression via interacting with DDX5. J Hematol Oncol 11:113","journal-title":"J Hematol Oncol"},{"key":"6116_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13045-018-0555-y","volume":"11","author":"MQ Cao","year":"2018","unstructured":"Cao MQ, You AB, Zhu XD, Zhang W, Zhang YY, Zhang SZ, Zhang KW, Cai H, Shi WK, Li XL, Li KS, Gao DM, Ma DN, Ye BG, Wang CH, Qin CD, Sun HC, Zhang T, Tang ZY (2018) miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. J Hematol Oncol 11:12","journal-title":"J Hematol Oncol"},{"key":"6116_CR14","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.3390\/ijms21144852","volume":"21","author":"A Gajos-Michniewicz","year":"2020","unstructured":"Gajos-Michniewicz A, Czyz M (2020) WNT signaling in melanoma. Int J Mol Sci 21:4852","journal-title":"Int J Mol Sci"},{"key":"6116_CR15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.28888","volume":"65","author":"P Sumazin","year":"2017","unstructured":"Sumazin P, Chen Y, Trevi\u00f1o LR et al (2017) Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology 65:104\u2013121","journal-title":"Hepatology"},{"key":"6116_CR16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.humpath.2017.10.007","volume":"70","author":"H Lee","year":"2017","unstructured":"Lee H, El Jabbour T, Ainechi S, Gay LM, Elvin JA, Vergilio JA, Suh J, Ramkissoon SH, Ali SM, Schrock A, Fabrizio D, Frampton G, Nazeer T, Miller VA, Stephens PJ, Ross JS (2017) General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study. Hum Pathol 70:84\u201391","journal-title":"Hum Pathol"},{"key":"6116_CR17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.str.2007.12.021","volume":"16","author":"Y Xing","year":"2008","unstructured":"Xing Y, Takemaru K, Liu J, Berndt JD, Zheng JJ, Moon RT, Xu W (2008) Crystal structure of a full-length beta-catenin. Structure 16:478\u2013487","journal-title":"Structure"},{"key":"6116_CR18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0092-8674(01)00330-0","volume":"105","author":"AH Huber","year":"2001","unstructured":"Huber AH, Weis WI (2001) The structure of the beta-catenin\/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell 105:391\u2013402","journal-title":"Cell"},{"key":"6116_CR19","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.18632\/oncotarget.23695","volume":"9","author":"C Gao","year":"2017","unstructured":"Gao C, Wang Y, Broaddus R, Sun L, Xue F, Zhang W (2017) Exon 3 mutations of CTNNB1 drive tumorigenesis: a review. Oncotarget 9:5492\u20135508","journal-title":"Oncotarget"},{"key":"6116_CR20","first-page":"269","volume":"59","author":"A Koch","year":"1999","unstructured":"Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T (1999) Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Cancer Res 59:269\u2013273","journal-title":"Cancer Res"},{"key":"6116_CR21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.humpath.2008.07.022","volume":"40","author":"D L\u00f3pez-Terrada","year":"2009","unstructured":"L\u00f3pez-Terrada D, Gunaratne PH, Adesina AM, Pulliam J, Hoang DM, Nguyen Y, Mistretta TA, Margolin J, Finegold MJ (2009) Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum Pathol 40:783\u2013794","journal-title":"Hum Pathol"},{"key":"6116_CR22","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","volume":"61","author":"M Eichenm\u00fcller","year":"2014","unstructured":"Eichenm\u00fcller M, Trippel F, Kreuder M, Beck A, Schwarzmayr T, H\u00e4berle B, Cairo S, Leuschner I, von Schweinitz D, Strom TM, Kappler R (2014) The genomic landscape of hepatoblastoma and their progenies with HCC-like features. J Hepatol 61:1312\u20131320","journal-title":"J Hepatol"},{"key":"6116_CR23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s41241-017-0021-0","volume":"37","author":"TFM Aguiar","year":"2017","unstructured":"Aguiar TFM, Carneiro TN (2017) The genetic and epigenetic landscapes of hepatoblastomas. Appl Cancer Res 37:20","journal-title":"Appl Cancer Res"},{"key":"6116_CR24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13027-020-00297-5","volume":"15","author":"D Javanmard","year":"2020","unstructured":"Javanmard D, Najafi M, Babaei MR, Karbalaie Niya MH, Esghaei M, Panahi M, Safarnezhad TF, Tavakoli A, Jazayeri SM, Ghaffari H, Ataei-Pirkooh A, Monavari SH, Bokharaei-Salim F (2020) Investigation of CTNNB1 gene mutations and expression in hepatocellular carcinoma and cirrhosis in association with hepatitis B virus infection. Infect Agent Cancer 15:37","journal-title":"Infect Agent Cancer"},{"key":"6116_CR25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/mutage\/ges027","volume":"27","author":"S Wang","year":"2012","unstructured":"Wang S, Tian Y, Wu D, Zhu H, Luo D, Gong W, Zhou Y, Zhou J, Zhang Z (2012) Genetic variation of CTNNB1 gene is associated with susceptibility and prognosis of gastric cancer in a Chinese population. Mutagenesis 27:623\u2013630","journal-title":"Mutagenesis"},{"key":"6116_CR26","doi-asserted-by":"crossref","first-page":"8276","DOI":"10.1158\/0008-5472.CAN-10-2014","volume":"70","author":"B Ragazzon","year":"2010","unstructured":"Ragazzon B, Lib\u00e9 R, Gaujoux S, Assi\u00e9 G, Fratticci A, Launay P, Clauser E, Bertagna X, Tissier F, de Reyni\u00e8s A, Bertherat J (2010) Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers. Cancer Res 70:8276\u20138281","journal-title":"Cancer Res"},{"key":"6116_CR27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1476-4598-7-53","volume":"7","author":"P Bj\u00f6rklund","year":"2008","unstructured":"Bj\u00f6rklund P, Lindberg D, Akerstr\u00f6m G, Westin G (2008) Stabilizing mutation of CTNNB1\/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients. Mol Cancer 7:53","journal-title":"Mol Cancer"},{"key":"6116_CR28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/1097-0045(20001201)45:4<323::AID-PROS7>3.0.CO;2-W","volume":"45","author":"DR Chesire","year":"2000","unstructured":"Chesire DR, Ewing CM, Sauvageot J, Bova GS, Isaacs WB (2000) Detection and analysis of beta-catenin mutations in prostate cancer. Prostate 45:323\u2013334","journal-title":"Prostate"},{"key":"6116_CR29","doi-asserted-by":"crossref","first-page":"e0135865","DOI":"10.1371\/journal.pone.0135865","volume":"10","author":"YM Jia","year":"2015","unstructured":"Jia YM, Xie YT, Wang YJ, Han JY, Tian XX, Fang WG (2015) Association of genetic polymorphisms in CDH1 and CTNNB1 with breast cancer susceptibility and patients\u2019 prognosis among Chinese Han women. PLoS ONE 10:e0135865","journal-title":"PLoS ONE"},{"key":"6116_CR30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/hupa.2002.30723","volume":"33","author":"P Machin","year":"2002","unstructured":"Machin P, Catasus L, Pons C, Mu\u00f1oz J, Matias-Guiu X, Prat J (2002) CTNNB1 mutations and beta-catenin expression in endometrial carcinomas. Hum Pathol 33:206\u2013212","journal-title":"Hum Pathol"},{"key":"6116_CR31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/PAS.0000000000001553","volume":"45","author":"RE Zyla","year":"2021","unstructured":"Zyla RE, Olkhov-Mitsel E, Amemiya Y, Bassiouny D, Seth A, Djordjevic B, Nofech-Mozes S, Parra-Herran C (2021) CTNNB1 mutations and aberrant \u03b2-catenin expression in ovarian endometrioid carcinoma: correlation with patient outcome. Am J Surg Pathol 45:68\u201376","journal-title":"Am J Surg Pathol"},{"key":"6116_CR32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/ERC-16-0546","volume":"24","author":"L Morandi","year":"2017","unstructured":"Morandi L, Righi A, Maletta F, Rucci P, Pagni F, Gallo M, Rossi S, Caporali L, Sapino A, Lloyd RV, Asioli S (2017) Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma. Endocr Relat Cancer 24:107\u2013117","journal-title":"Endocr Relat Cancer"},{"key":"6116_CR33","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J (2018) fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34:i884\u2013i890","journal-title":"Bioinformatics"},{"key":"6116_CR34","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25:1754\u20131760","journal-title":"Bioinformatics"},{"key":"6116_CR35","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA (2010) The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297\u20131303","journal-title":"Genome Res"},{"key":"6116_CR36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucl Acids Res 29:308\u2013311","journal-title":"Nucl Acids Res"},{"key":"6116_CR37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR (2015) A global reference for human genetic variation. Nature 526:68\u201374","journal-title":"Nature"},{"key":"6116_CR38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13073-020-00803-9","volume":"12","author":"X Liu","year":"2020","unstructured":"Liu X, Li C, Mou C, Dong Y, Tu Y (2020) dbNSFP v4: a comprehensive database of transcript-specific functional predictions and annotations for human nonsynonymous and splice-site SNVs. Genome Med 12:103","journal-title":"Genome Med"},{"key":"6116_CR39","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/humu.24309","volume":"43","author":"S Gudmundsson","year":"2022","unstructured":"Gudmundsson S, Singer-Berk M, Watts NA, Phu W, Goodrich JK, Solomonson M, Genome Aggregation Database Consortium, Rehm HL, MacArthur DG, O\u2019Donnell-Luria A (2022) Variant interpretation using population databases: lessons from gnomAD. Hum Mutat 43:1012\u20131030","journal-title":"Hum Mutat"},{"key":"6116_CR40","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, Maglott DR (2014) ClinVar: public archive of relationships among sequence variation and human phenotype. Nucl Acids Res 42:D980\u2013D985","journal-title":"Nucl Acids Res"},{"key":"6116_CR41","doi-asserted-by":"crossref","first-page":"D514","DOI":"10.1093\/nar\/gki033","volume":"33","author":"A Hamosh","year":"2005","unstructured":"Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA (2005) Online mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucl Acids Res 33:D514\u2013D517","journal-title":"Nucl Acids Res"},{"key":"6116_CR42","first-page":"pl1","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:pl1","journal-title":"Sci Signal"},{"key":"6116_CR43","doi-asserted-by":"crossref","first-page":"W344","DOI":"10.1093\/nar\/gkw408","volume":"44","author":"H Ashkenazy","year":"2016","unstructured":"Ashkenazy H, Abadi S, Martz E, Chay O, Mayrose I, Pupko T, Ben-Tal N (2016) ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucl Acids Res 44:W344\u2013W350","journal-title":"Nucl Acids Res"},{"key":"6116_CR44","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, Bork P, Jensen LJ, von Mering C (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucl Acids Res 51:D638\u2013D646","journal-title":"Nucl Acids Res"},{"key":"6116_CR45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12864-016-2722-2","volume":"17","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Plaschkes I, Oz-Levi D, Alkelai A, Olender T, Zimmerman S, Lancet D (2016) VarElect: the phenotype-based variation prioritizer of the GeneCards suite. BMC Genom 17:195\u2013206","journal-title":"BMC Genom"},{"key":"6116_CR46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jdermsci.2005.09.005","volume":"41","author":"J Xia","year":"2006","unstructured":"Xia J, Urabe K, Moroi Y, Koga T, Duan H, Li Y, Furue M (2006) beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas. J Dermatol Sci 41:67\u201375","journal-title":"J Dermatol Sci"},{"key":"6116_CR47","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/emboj\/18.9.2401","volume":"18","author":"M Kitagawa","year":"1999","unstructured":"Kitagawa M, Hatakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K, Nakamichi I, Kikuchi A, Nakayama K, Nakayama K (1999) An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. EMBO J 18:2401\u20132410","journal-title":"EMBO J"},{"key":"6116_CR48","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/382638a0","volume":"382","author":"J Behrens","year":"1996","unstructured":"Behrens J, von Kries JP, K\u00fchl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638\u2013642","journal-title":"Nature"},{"key":"6116_CR49","first-page":"1","volume":"77","author":"N Barker","year":"2000","unstructured":"Barker N, Morin PJ, Clevers H (2000) The Yin-Yang of TCF\/beta-catenin signaling. Adv Cancer Res 77:1\u201324","journal-title":"Adv Cancer Res"},{"key":"6116_CR50","first-page":"4257","volume":"59","author":"WS Park","year":"1999","unstructured":"Park WS, Oh RR, Park JY, Lee SH, Shin MS, Kim YS, Kim SY, Lee HK, Kim PJ, Oh ST, Yoo NJ, Lee JY (1999) Frequent somatic mutations of the beta-catenin gene in intestinal-type gastric cancer. Cancer Res 59:4257\u20134260","journal-title":"Cancer Res"},{"issue":"7","key":"6116_CR51","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00000478-200407000-00012","volume":"28","author":"Y Nakatani","year":"2004","unstructured":"Nakatani Y, Miyagi Y, Takemura T, Oka T, Yokoi T, Takagi M, Yokoyama S, Kashima K, Hara K, Yamada T, Nozawa A, Inayama Y, Sakamoto K, Ogawa N, Kitamura H, Resl M, Cho SH, Koss MN, Mark EJ (2004) Aberrant nuclear\/cytoplasmic localization and gene mutation of beta-catenin in classic pulmonary blastoma: beta-catenin immunostaining is useful for distinguishing between classic pulmonary blastoma and a blastomatoid variant of carcinosarcoma. Am J Surg Pathol 28(7):921\u2013927","journal-title":"Am J Surg Pathol"},{"key":"6116_CR52","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0002-9440(10)65168-1","volume":"155","author":"JT Nhieu","year":"1999","unstructured":"Nhieu JT, Renard CA, Wei Y, Cherqui D, Zafrani ES, Buendia MA (1999) Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Pathol 155:703\u2013710","journal-title":"Am J Pathol"},{"key":"6116_CR53","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1038\/sj.onc.1202800","volume":"18","author":"P Legoix","year":"1999","unstructured":"Legoix P, Bluteau O, Bayer J, Perret C, Balabaud C, Belghiti J, Franco D, Thomas G, Laurent-Puig P, Zucman-Rossi J (1999) Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Oncogene 18:4044\u20134046","journal-title":"Oncogene"},{"key":"6116_CR54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/carcin\/23.1.87","volume":"23","author":"MP Ebert","year":"2002","unstructured":"Ebert MP, Fei G, Kahmann S, M\u00fcller O, Yu J, Sung JJ, Malfertheiner P (2002) Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 23:87\u201391","journal-title":"Carcinogenesis"},{"key":"6116_CR55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nbt.3391","volume":"34","author":"MT Chang","year":"2016","unstructured":"Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, Gao J, Socci ND, Solit DB, Olshen AB, Schultz N, Taylor BS (2016) Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat Biotechnol 34:155\u2013163","journal-title":"Nat Biotechnol"},{"key":"6116_CR56","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.gendis.2023.03.012","volume":"11","author":"M Wu","year":"2023","unstructured":"Wu M, Dong H, Xu C, Sun M, Gao H, Bu F, Chen J (2023) The Wnt-dependent and Wnt-independent functions of BCL9 in development, tumorigenesis, and immunity: implications in therapeutic opportunities. Genes Dis 11:701\u2013710","journal-title":"Genes Dis"},{"key":"6116_CR57","doi-asserted-by":"crossref","first-page":"148ra117","DOI":"10.1126\/scitranslmed.3003808","volume":"4","author":"K Takada","year":"2012","unstructured":"Takada K, Zhu D, Bird GH, Sukhdeo K, Zhao JJ, Mani M, Lemieux M, Carrasco DE, Ryan J, Horst D, Fulciniti M, Munshi NC, Xu W, Kung AL, Shivdasani RA, Walensky LD, Carrasco DR (2012) Targeted disruption of the BCL9\/\u03b2-catenin complex inhibits oncogenic Wnt signaling. Sci Transl Med 4:148ra117","journal-title":"Sci Transl Med"},{"key":"6116_CR58","doi-asserted-by":"crossref","first-page":"e0199837","DOI":"10.1371\/journal.pone.0199837","volume":"13","author":"SL O'Beirne","year":"2018","unstructured":"O\u2019Beirne SL, Salit J, Rodriguez-Flores JL et al (2018) Exome sequencing-based identification of novel type 2 diabetes risk allele loci in the Qatari population. PLoS ONE 13:e0199837","journal-title":"PLoS ONE"},{"key":"6116_CR59","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.4049\/jimmunol.1102282","volume":"189","author":"T Yaguchi","year":"2012","unstructured":"Yaguchi T, Goto Y, Kido K, Mochimaru H, Sakurai T, Tsukamoto N, Kudo-Saito C, Fujita T, Sumimoto H, Kawakami Y (2012) Immune suppression and resistance mediated by constitutive activation of Wnt\/\u03b2-catenin signaling in human melanoma cells. J Immunol 189:2110\u20132117","journal-title":"J Immunol"},{"key":"6116_CR60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","volume":"5","author":"W Zou","year":"2005","unstructured":"Zou W (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 5:263\u2013274","journal-title":"Nat Rev Cancer"},{"key":"6116_CR61","doi-asserted-by":"crossref","first-page":"107043","DOI":"10.1016\/j.intimp.2020.107043","volume":"89","author":"X Xiao","year":"2020","unstructured":"Xiao X, Mo H, Tu K (2020) CTNNB1 mutation suppresses infiltration of immune cells in hepatocellular carcinoma through miRNA-mediated regulation of chemokine expression. Int Immunopharmacol 89:107043","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"6116_CR62","first-page":"dju245","volume":"106","author":"Y Liu","year":"2014","unstructured":"Liu Y, Patel L, Mills GB, Lu KH, Sood AK, Ding L, Kucherlapati R, Mardis ER, Levine DA, Shmulevich I, Broaddus RR, Zhang W (2014) Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma. J Natl Cancer Inst 106(9):dju245","journal-title":"J Natl Cancer Inst"},{"key":"6116_CR63","first-page":"8","volume":"7","author":"SA Kwee","year":"2021","unstructured":"Kwee SA, Tiirikainen M (2021) Beta-catenin activation and immunotherapy resistance in hepatocellular carcinoma: mechanisms and biomarkers. Hepatoma Res 7:8","journal-title":"Hepatoma Res"},{"key":"6116_CR64","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.7150\/jca.71494","volume":"13","author":"K Ogawa","year":"2022","unstructured":"Ogawa K, Kanzaki H, Chiba T, Ao J, Qiang N, Ma Y, Zhang J, Yumita S, Ishino T, Unozawa H, Kan M, Iwanaga T, Nakagawa M et al (2022) Effect of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma harboring CTNNB1 mutation in early clinical experience. J Cancer 13:2656\u20132661","journal-title":"J Cancer"},{"issue":"2","key":"6116_CR65","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00404-021-06385-0","volume":"306","author":"A Travaglino","year":"2022","unstructured":"Travaglino A, Raffone A, Raimondo D, Reppuccia S, Ruggiero A, Arena A, Casadio P, Zullo F, Insabato L, Seracchioli R, Mollo A (2022) Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis. Arch Gynecol Obstet 306(2):423\u2013431","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"6116_CR66","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1111\/cas.15328","volume":"113","author":"M Kobayashi Kato","year":"2022","unstructured":"Kobayashi Kato M, Asami Y, Takayanagi D, Matsuda M, Shimada Y, Hiranuma K, Kuno I, Komatsu M, Hamamoto R, Matsumoto K, Ishikawa M, Kohno T, Kato T, Shiraishi K, Yoshida H (2022) Clinical impact of genetic alterations of CTNNB1 in patients with grade 3 endometrial endometrioid carcinoma. Cancer Sci 113(5):1712\u20131721","journal-title":"Cancer Sci"},{"issue":"5","key":"6116_CR67","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2353\/ajpath.2008.080475","volume":"173","author":"AJ Lazar","year":"2008","unstructured":"Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, Warneke CL, Lopez-Terrada D, Pollock RE, Lev D (2008) Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 173(5):1518\u20131527","journal-title":"Am J Pathol"},{"issue":"11","key":"6116_CR68","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1158\/1535-7163.MCT-17-0342","volume":"16","author":"GJR Zaman","year":"2017","unstructured":"Zaman GJR, de Roos JADM, Libouban MAA, Prinsen MBW, de Man J, Buijsman RC, Uitdehaag JCM (2017) TTK inhibitors as a targeted therapy for CTNNB1 (\u03b2-catenin) mutant cancers. Mol Cancer Ther 16(11):2609\u20132617","journal-title":"Mol Cancer Ther"},{"key":"6116_CR69","doi-asserted-by":"crossref","unstructured":"Anurima Majumder, Benjamin S. Meyer, J Kevin Hicks, Theresa A. Boyle, Eric B. Haura (2022). CTNNB1 mutation can mediate resistance to EGFR, ALK and KRAS targeted therapies [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 8\u201313. Philadelphia (PA): AACR; Cancer Res 2022; 82 (12_Suppl):Abstract nr 1101","DOI":"10.1158\/1538-7445.AM2022-1101"},{"issue":"6","key":"6116_CR70","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/gutjnl-2023-331342","volume":"73","author":"N Cai","year":"2024","unstructured":"Cai N, Cheng K, Ma Y, Liu S, Tao R, Li Y, Li D, Guo B, Jia W, Liang H, Zhao J, Xia L, Ding ZY, Chen J, Zhang W (2024) Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8+ T cell-mediated antitumour immunity and improves anti-PD-1 efficacy. Gut 73(6):985\u2013999","journal-title":"Gut"},{"issue":"1","key":"6116_CR71","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.phoj.2020.09.001","volume":"6","author":"A Jov\u00e9 Blanco","year":"2021","unstructured":"Jov\u00e9 Blanco A, Huerta Aragon\u00e9s J, Mata Fern\u00e1ndez C (2021) Target therapy with celecoxib in pediatric recurrent desmoid tumors a case report. Pediatr Hematol Oncol J 6(1):60\u201362","journal-title":"Pediatr Hematol Oncol J"},{"issue":"2","key":"6116_CR72","first-page":"269","volume":"59","author":"A Koch","year":"1999","unstructured":"Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T (1999) Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene. Can Res 59(2):269\u2013273","journal-title":"Can Res"},{"issue":"4","key":"6116_CR73","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<399::AID-GCC14>3.0.CO;2-X","volume":"25","author":"H Bl\u00e4ker","year":"1999","unstructured":"Bl\u00e4ker H, Hofmann WJ, Rieker RJ, Penzel R, Graf M, Otto HF (1999) Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma. Genes Chromosom Cancer 25(4):399\u2013402","journal-title":"Genes Chromosom Cancer"},{"issue":"11","key":"6116_CR74","doi-asserted-by":"crossref","first-page":"e28594","DOI":"10.1002\/pbc.28594","volume":"67","author":"S Kahana-Edwin","year":"2020","unstructured":"Kahana-Edwin S, McCowage G, Cain L, Saletta F, Yuksel A, Graf N, Karpelowsky J (2020) Exploration of CTNNB1 ctDNA as a putative biomarker for hepatoblastoma. Pediatr Blood Cancer 67(11):e28594","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"6116_CR75","doi-asserted-by":"crossref","first-page":"BSR20192466","DOI":"10.1042\/BSR20192466","volume":"39","author":"YL Sha","year":"2019","unstructured":"Sha YL, Liu S, Yan WW, Dong B (2019) Wnt\/\u03b2-catenin signaling as a useful therapeutic target in hepatoblastoma. Biosci Rep 39(9):BSR20192466","journal-title":"Biosci Rep"},{"issue":"3","key":"6116_CR76","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2014.05.004","volume":"147","author":"J Tao","year":"2014","unstructured":"Tao J, Calvisi DF, Ranganathan S, Cigliano A, Zhou L, Singh S, Jiang L, Fan B, Terracciano L, Armeanu-Ebinger S, Ribback S, Dombrowski F, Evert M, Chen X, Monga SPS (2014) Activation of \u03b2-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. Gastroenterology 147(3):690\u2013701","journal-title":"Gastroenterology"},{"key":"6116_CR77","doi-asserted-by":"crossref","first-page":"153829","DOI":"10.1016\/j.prp.2022.153829","volume":"232","author":"W Jiang","year":"2022","unstructured":"Jiang W, Ou ZL, Zhu Q, Yao YB, Zai HY (2022) LncRNA OIP5-AS1 aggravates the stemness of hepatoblastoma through recruiting PTBP1 to increase the stability of \u03b2-catenin. Pathol Res Pract 232:153829","journal-title":"Pathol Res Pract"},{"issue":"5","key":"6116_CR78","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11897-015-0264-6","volume":"12","author":"E Kayvanpour","year":"2015","unstructured":"Kayvanpour E, Katus HA, Meder B (2015) Determined to fail\u2013the role of genetic mechanisms in heart failure. Curr Heart Fail Rep 12(5):333\u2013338","journal-title":"Curr Heart Fail Rep"},{"issue":"15","key":"6116_CR79","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1182\/blood-2016-03-701698","volume":"127","author":"NS Key","year":"2016","unstructured":"Key NS, Reiner AP (2016) Genetic basis of ethnic disparities in VTE risk. Blood 127(15):1844\u20131845","journal-title":"Blood"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-025-06116-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00383-025-06116-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-025-06116-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:26:44Z","timestamp":1763630804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00383-025-06116-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6116"],"URL":"https:\/\/doi.org\/10.1007\/s00383-025-06116-5","relation":{},"ISSN":["1437-9813"],"issn-type":[{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"4 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"233"}}